Skip to main content

GOLDMAN SACHS GROUP INC

Position in DNTH — Dianthus Therapeutics, Inc. /DE/

CIK 886982 NEW YORK, NY

Position in DNTH

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$45,988,998
+$22,210,046 QoQ
Shares Held
548,010
-5.0% QoQ
Ownership
1.00%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 95.17162095582198.ToString("F0")% Shared 0.ToString("F0")% None 4.828379044178026.ToString("F0")%

Common Shares in DNTH Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,293,152,367 across 364 Biotechnology names. DNTH ranks #54 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DNTH

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $45,988,998 548,010
2025-12-31 $23,778,952 577,019
2025-09-30 $8,608,637 218,771
2025-06-30 $6,792,348 364,592
2025-03-31 $1,332,019 73,430
2024-12-31 $4,535,860 208,067
2024-09-30 $2,206,991 80,606
2024-06-30 $1,083,569 41,869
2024-03-31 $5,106,510 170,217